First Allied Advisory Services Inc. decreased its holdings in Nutrien Ltd (NYSE:NTR) by 11.8% in the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 8,978 shares of the company’s stock after selling 1,198 shares during the quarter. First Allied Advisory Services Inc.’s holdings in Nutrien were worth $489,000 as of its most recent filing with the Securities & Exchange Commission.
A number of other hedge funds have also made changes to their positions in the stock. Morningstar Investment Services LLC lifted its stake in Nutrien by 6.8% in the second quarter. Morningstar Investment Services LLC now owns 14,693 shares of the company’s stock worth $799,000 after acquiring an additional 933 shares during the period. Thomas White International Ltd. lifted its stake in Nutrien by 1.7% in the second quarter. Thomas White International Ltd. now owns 67,642 shares of the company’s stock worth $3,678,000 after acquiring an additional 1,106 shares during the period. Cypress Capital Management LLC lifted its stake in Nutrien by 0.9% in the second quarter. Cypress Capital Management LLC now owns 194,133 shares of the company’s stock worth $10,557,000 after acquiring an additional 1,653 shares during the period. Whittier Trust Co. lifted its stake in Nutrien by 253.2% in the second quarter. Whittier Trust Co. now owns 2,790 shares of the company’s stock worth $152,000 after acquiring an additional 2,000 shares during the period. Finally, Tdam USA Inc. lifted its stake in Nutrien by 17.8% in the second quarter. Tdam USA Inc. now owns 13,656 shares of the company’s stock worth $743,000 after acquiring an additional 2,062 shares during the period. 66.27% of the stock is owned by institutional investors.
NTR opened at $57.05 on Friday. The company has a quick ratio of 1.58, a current ratio of 2.07 and a debt-to-equity ratio of 0.45. The firm has a market capitalization of $34.88 billion, a price-to-earnings ratio of 44.96, a PEG ratio of 1.58 and a beta of 0.67. Nutrien Ltd has a 12-month low of $40.41 and a 12-month high of $58.70.
Nutrien (NYSE:NTR) last posted its quarterly earnings data on Wednesday, August 1st. The company reported $1.48 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.40 by $0.08. The business had revenue of $8.15 billion during the quarter, compared to the consensus estimate of $7.70 billion. Nutrien had a return on equity of 10.27% and a net margin of 9.83%. The business’s revenue for the quarter was up 10.8% on a year-over-year basis. equities analysts predict that Nutrien Ltd will post 2.55 earnings per share for the current year.
The company also recently disclosed a quarterly dividend, which will be paid on Friday, October 19th. Shareholders of record on Friday, September 28th will be issued a $0.40 dividend. The ex-dividend date is Thursday, September 27th. This represents a $1.60 dividend on an annualized basis and a yield of 2.80%.
A number of analysts recently commented on NTR shares. Raymond James raised Nutrien from an “outperform” rating to a “strong-buy” rating and raised their price target for the stock from $60.00 to $65.00 in a research note on Monday, June 25th. Zacks Investment Research raised Nutrien from a “hold” rating to a “buy” rating and set a $61.00 price target for the company in a research note on Thursday, August 2nd. Stephens set a $64.00 price target on Nutrien and gave the stock a “buy” rating in a research note on Monday, August 6th. Royal Bank of Canada raised their price target on Nutrien from $55.00 to $60.00 and gave the stock an “outperform” rating in a research note on Wednesday, July 18th. Finally, Citigroup raised their price target on Nutrien from $56.00 to $62.00 and gave the stock a “buy” rating in a research note on Wednesday, July 11th. One research analyst has rated the stock with a sell rating, eight have assigned a hold rating, ten have assigned a buy rating and one has issued a strong buy rating to the company. The company presently has an average rating of “Buy” and an average price target of $61.13.
Nutrien Ltd. produces and markets crop nutrients worldwide. The company offers potash, nitrogen, phosphate, and solid and liquid phosphate fertilizers; and phosphate feed, ammonium sulfate, and industrial acid products. It also retails seeds, crop protection and crop nutrient products, merchandise products, and agronomic services through operating 1,500 retail locations.
Read More: NASDAQ
Want to see what other hedge funds are holding NTR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Nutrien Ltd (NYSE:NTR).
Receive News & Ratings for Nutrien Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nutrien and related companies with MarketBeat.com's FREE daily email newsletter.